DIFFERIN EPIDUO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Differin Epiduo, and what generic alternatives are available?
Differin Epiduo is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in DIFFERIN EPIDUO is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Differin Epiduo
A generic version of DIFFERIN EPIDUO was approved as adapalene; benzoyl peroxide by PADAGIS ISRAEL on January 23rd, 2018.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIFFERIN EPIDUO?
- What are the global sales for DIFFERIN EPIDUO?
- What is Average Wholesale Price for DIFFERIN EPIDUO?
Summary for DIFFERIN EPIDUO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in DIFFERIN EPIDUO? | DIFFERIN EPIDUO excipients list |
| DailyMed Link: | DIFFERIN EPIDUO at DailyMed |
US Patents and Regulatory Information for DIFFERIN EPIDUO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | DIFFERIN EPIDUO | adapalene; benzoyl peroxide | GEL;TOPICAL | 220736-001 | May 22, 2026 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
